Market Pulse · Daily Scan
Daily Market Pulse
Jul 29, 2026 · sentiment/flow window ≈ 48h
Pre-marketnot publishedPost-market
TLDR;
Hawkish-repricing stagflation risk layered on an AI-capex credibility crisis. The FOMC held at 3.50-3.75% on Jul 29 but THREE governors/presidents dissented in favor of a 25bp HIKE (Hammack, Kashkari, Logan) - the most hawkish-direction dissents since Sep 2016. New Chair Kevin Warsh's first press conference was read as behind-the-curve on inflation. Simultaneously Iran's IRGC fired ballistic missiles at US forces in Jordan (all intercepted), collapsing a week-old ceasefire and lifting crude ~7%. The reflexive loop that defined the session: geopolitics -> energy -> inflation -> hawkish Fed -> long-end yields -> equity multiple compression. Underneath it, the memory/semi complex was already in a historic drawdown after China's CXMT IPO closed +466% on the Shanghai STAR board (Jul 27) and Korea's KOSPI tripped circuit breakers on consecutive sessions. Breadth: Broad, not narrow. Decliners beat advancers 1.8:1 on the S&P 500; 9 of 11 sectors negative; Nasdaq 121 new highs vs 230 new lows; S&P 32 highs / 4 lows. Volume 17.7bn shares vs 17.3bn 20-session average (conviction selling). Notably the Russell 2000 (-1.61%) fell LESS than the Dow (-2.19%) - this was a mega-cap/industrial/semiconductor unwind, not a small-cap risk-off. Russell remains +17.1% YTD vs S&P +6.9%..A · Daily Pulse
What moved — and why
▲ Rising — dailycomposite
| # | Ticker | Move | Driver | Score |
|---|---|---|---|---|
| 1 | MANH | — | Reported Q2 record results: cloud revenue +26%, third consecutive quarter of record bookings, and raised FY26 revenue, operating margin and EPS guidance. Cleanest Tier-1-grade catalyst-to-move ratio in the universe on Jul 29 and the largest verified gain among names passing the $10B filter. Mcap $11.1B sits close to the threshold - verify before sizing. | 72 |
| 2 | GRMN | — | Record Q2: adjusted EPS $2.81 vs $2.29 consensus; raised FY revenue to $8.05B and pro-forma EPS to $10.00. A consumer-hardware beat in a tape that was punishing hardware - genuine idiosyncratic alpha, not sector drift. | 69 |
| 3 | GEHC | — | Q2 beat with record orders and backlog; organic revenue +3.5%; affirmed FY26 adjusted EPS $4.80-$5.00. Healthcare was one of only two green sectors on Jul 28 (XLV made an all-time high) and GEHC carried that into Jul 29 - defensive rotation with a company-specific print behind it. | 67 |
| 4 | IQV | — | Q2 revenue beat at $4.37B with raised FY2026 EPS guidance, delivered on Jul 28 and held the gain through the Jul 29 selloff (+1.9% on a -1.5% tape). Holding a 14% gap in a broad-decline session is itself the signal. | 65 |
| 5 | APH | — | Record Q2: adjusted EPS $1.35 vs $1.19, sales +55% y/y to $8.8B, record orders and a 1.23:1 book-to-bill, plus CommScope accretion. The only AI-infrastructure-adjacent name to rally on Jul 29 while the rest of the complex was liquidated - connector/interconnect content is being treated as durable where memory and equipment are not. | 64 |
| 6 | CTSH | — | Q2 revenue +4.1% with margin expansion and AI-led deal wins including an expanded Anthropic partnership. Counter-narrative to the 'AI disintermediates IT services' short thesis that has de-rated ACN and peers. NOTE: the +7.7% figure appears in one source chain and was not independently reconciled against a second close - treat magnitude as provisional. | 63 |
| 7 | XOM | — | Pure oil beta. IRGC missile launch at US forces in Jordan plus a Houthi attack on a Saudi tanker threatening Bab-el-Mandeb sent WTI +6.56% to $84.46 and Brent ~+7%. Energy (+1.9%) was the only meaningfully green sector in a 9-of-11-red tape. Note the two-sided setup: XOM was downgraded to Neutral at BofA on Jul 28, and the move is headline-driven, not estimate-driven. Reports Jul 31 BMO; OPEC+ meets Aug 2. | 63 |
| 8 | CVX | — | Same crude catalyst as XOM. Reports Jul 31 BMO with OPEC+ meeting Aug 2 - two scheduled catalysts inside the horizon on top of a live geopolitical premium. | 61 |
| 9 | AMT | — | Q2 earnings beat plus raised annual outlook. Analytically the odd one out: a long-duration REIT rallying 4.5% on a day the 30-year hit a 19-year high above 5.20% should not happen on rates alone, which argues the move is genuinely company-specific rather than a duration bid. Market cap comfortably above threshold as a large-cap REIT but not independently pulled - flagged. | 59 |
| 10 | F | — | Q2 adjusted EPS $0.42 vs $0.35 and raised FY26 operating profit guidance to $10B-$11B from $8.5B-$10.5B - one of the largest guidance raises in the window. Rose on both sessions, which is rare in this tape. Mcap not independently pulled; Ford is well above $10B but flagged for form. | 56 |
▼ Falling — dailycomposite
| # | Ticker | Move | Driver | Score |
|---|---|---|---|---|
| 1 | MU | — | Epicenter of the memory unwind. China's CXMT IPO'd on the Shanghai STAR board Jul 27 and closed +466%, described by one analyst as memory's 'DeepSeek moment'; Korea's KOSPI tripped circuit breakers on consecutive sessions and SK Hynix fell 11% on a record print after guiding capex +50% to $31B. MU fell on both sessions on ~69.8M shares. Critically, retail was SELLING: Vanda Research reported retail investors sold the most single stocks since Covid with semis at 88% of the selling - so the elevated WSB mention count is capitulation chatter, not accumulation. That distinction is why pump_risk is FALSE despite Tier-3 dominance. DATA CONFLICT: one source lists the Jul 29 close at both $775 (-6%) and $739 (-9.94%); the $987.54B market cap (stockanalysis, Jul 30) is hard to reconcile with a -36% July drawdown from a $963.59B mid-July cap. Treat mcap and close as provisional; universe qualification is not in doubt at any of these figures. ↔ deep-dive | 84 |
| 2 | SNDK | — | Down ~36% over five sessions in the memory liquidation, having been up +2,881% over 52 weeks. PUMP_RISK is flagged on flow characteristics - a +606% one-day Reddit mention spike, documented premarket spikes following WSB attention, and +/-15% daily swings - but the caveat matters: SanDisk has ~$3.0B of operating cash flow, ~56% gross margin, ROE above 39% and a 4.8 current ratio. This is a crowded momentum battleground with real earnings underneath, not a hollow pump. The flag is a position-sizing warning, not a fraud signal. pump risk | 84 |
| 3 | VRT | — | Q2 revenue $3.27B missed $3.38B despite an EPS beat ($1.52 vs $1.43); the CEO attributed it to project timing and called it 'a temporary issue', and the FY26 guide was raised only modestly. In the current regime a data-center-infrastructure name is not granted the benefit of the doubt on a revenue miss - this is the AI-capex-revolt thesis expressed in a single print. The 30-day retail mention surge (+1,450%) means positioning was crowded into the event. | 81 |
| 4 | KLAC | — | The purest 'beat-and-raise rejection' in the window: KLA beat, guided to acceleration, disclosed RPO backlog +60% y/y to $12.5B - and was sold anyway, into its worst month on record going back to 1980. Multiple sell-side PT cuts followed. When a semicap leader cannot be rewarded for a 60% backlog build, the market is repricing the entire capex cycle rather than the company. Rare case in this list where the pre-event options skew (1:1.5 puts) actually called the direction. | 77 |
| 5 | NBIS | — | No company-specific catalyst on either session - this is pure de-rating of a high-multiple AI neocloud (market cap +284% y/y on TTM revenue of $878M, roughly 55x sales). PUMP_RISK is flagged for the reflexivity in both directions: NBIS fell 9.7% then 12.7%, then rose 26.18% on Jul 30 on a Tier-2/3 headline that a Vera Rubin compute rack had gone live in Finland - a story with no Tier-1 filing behind it. A 52-week range of $50.10-$299.86 tells you position sizing, not valuation, is the binding risk here. pump risk | 77 |
| 6 | SOFI | — | Sold off hard despite a beat-and-raise: record adjusted net revenue $1.2B and FY guidance lifted to $4.75-$4.85B, followed by a Morgan Stanley PT cut to $15. A retail-heavy fintech with a +1,700% 30-day mention surge and 2.5:1 pre-print call skew is exactly the positioning profile that unwinds violently when a good number is not enough - a rates-and-multiple story, not a credit story. | 75 |
| 7 | AMKR | — | Largest single-session decline of any name passing the universe filter: -24.74% on Jul 28 on a Q3 revenue guide of $1.95-$2.05B against $2.113B consensus, then a further -6.48%. Advanced packaging is the assembly layer of the AI stack, so a guide-down here is a demand-timing datapoint the rest of the complex traded off. Ranks 7th rather than 1st only because momentum is the sole high sub-score - options and sentiment are unverified or muted, so the composite is honest about how thin the evidence base is. | 72 |
| 8 | GLW | — | Beat on both lines (revenue $4.74B vs $4.63B, core EPS $0.78 vs $0.75) and fell 12% because optical segment growth decelerated to 32% from 36% and the Q3 optical guide disappointed. The market is now marking the SECOND DERIVATIVE of AI-linked growth, not the level - a 32% growth rate being treated as a disappointment is the single most useful framing datapoint in this list. | 68 |
| 9 | CAT | — | Largest Dow drag on Jul 29 after a Baird downgrade arguing regulatory action will raise costs, compounded by industrials being the worst sector (-3.2%). Deere fell 4.52% alongside on soft agricultural commodity prices. Reports Aug 4 BMO with consensus EPS $6.25 - the guidance will be read as a tariff/cost-inflation tell for the whole industrial complex. | 62 |
| 10 | NXPI | — | Beat and guided above (Q2 revenue $3.5B, +19% y/y; EPS $3.61 vs $3.53) and still fell 7%. Zero company-specific bad news - this is a clean read on sector beta, which is why it ranks last: the signal is about the SOX, not about NXP. | 57 |
B · One-Year Conviction
Asymmetric 12-month skew
Valuation and market-cap figures are from stockanalysis.com (Tier-2 aggregator republishing S&P Global Market Intelligence data) as of 2026-07-30 unless noted. Tier-1 primary sources verified directly this run: Micron FQ3-2026 press release via SEC EDGAR, NVIDIA Q1 FY2027 IR release, GE Vernova Q2-2026 IR press release, Alphabet Q2-2026 earnings slides, FOMC statement. Sell-side notes (Morgan Stanley, Goldman, Mizuho, UBS) were accessed only as quoted excerpts inside Tier-2 media, never as primary notes.
▲ Upside skew — 1yrconviction
| Ticker | Thesis | Key risk | Score |
|---|---|---|---|
| TSM | TSMC is the unavoidable chokepoint of the AI buildout and, unlike its customers, converts the capex boom into cash rather than consuming it. On the Q2 2026 call it raised full-year revenue growth guidance above 40% and lifted capex to $64B, with brokerages flagging EUV-driven capex and 2027 price hikes. It holds pricing power over Nvidia, AMD, Broadcom and Apple simultaneously. Best combination available of verified upward revisions, a below-market multiple on above-market growth, and a structural monopoly. | Taiwan geopolitical tail risk is the entire bear case and is not diversifiable; Customer concentration in Nvidia; Rising capex intensity compresses FCF conversion; A 2027 hyperscaler capex cut hits with a 2-3 quarter lag | 87 |
| NVDA | The stock has gone nowhere for twelve months while earnings roughly doubled - a two-thirds compression in the multiple. Q1 FY2027 (Tier 1, company IR): revenue $81.6B +85% y/y, data center $75.2B +92%, non-GAAP gross margin 75.0%, Q2 guide $91.0B +/-2% while ASSUMING ZERO China datacenter compute revenue, plus an $80B new buyback authorization. At 19.6x forward against 85% growth, the market has already discounted a substantial capex deceleration. Also worth noting for Track A context: retail chatter has ABANDONED it (ApeWisdom NVDA mentions -51% over 30 days) - the crowding has moved elsewhere. | Memory input-cost inflation is hitting the bill of materials - memory is now 29% of total cost against a stated ~20% target, forcing a halving of Vera Rubin memory from 192GB to 96GB per CPU and 20-30% consumer GPU price increases; $410.6M of insider selling over three months with zero buys; Custom-ASIC share loss to Broadcom/TPU/MTIA; Beta of 2.21 means it is the wrong vehicle if the capex thesis is wrong | 85 |
| MSFT | The only hyperscaler demonstrably MONETIZING AI at scale while still generating $67B of free cash flow. FQ4 2026 (reported after the close on RUN_DATE): revenue $90.01B +17.75%, Intelligent Cloud $39.31B +32%, Azure +43% y/y crossing $100B of annual revenue, commercial backlog $678B +84%, Copilot above 30M paid seats, operating margin 45.6%. The stock being down 12% over a year into accelerating cloud growth is a de-rating, not a deterioration. NOTE for audit: the +14.8% move that followed this print occurred on Jul 30 and is therefore OUTSIDE the RUN_DATE window - it is deliberately excluded from Track A. ↔ deep-dive | Capex up 84.4% y/y in a recent quarter; Azure growth is materially OpenAI-linked, concentrating exposure to one counterparty's funding; Options underpriced this print by ~2x (7.0-7.3% implied vs 14.8% realized), so the market's read on Microsoft is unstable in both directions | 83 |
| AVGO | The custom-ASIC leg is the structural AI trade: every hyperscaler dollar spent reducing Nvidia dependence is by definition spent with Broadcom. Q1 FY2026 AI semiconductor revenue $8.4B +106% y/y on total revenue $19.31B +29%, with an $73B AI backlog deliverable over 18 months - order-book visibility no merchant-silicon peer has. VMware software mix cushions semiconductor cyclicality. | Customer concentration (Google, Meta, OpenAI); The '$100B AI revenue in 2027' figure is a CEO statement on a call, NOT formal guidance - treat as management assertion, not fact; Trailing 61.6x reflects acquisition amortization so GAAP optics stay poor and screen badly | 81 |
| MU | SPLIT CONVICTION - stated as such rather than resolved. Bull: 5.15x forward earnings on a business posting 84.6% GAAP gross margins, with HBM wafer cannibalization keeping conventional DRAM tight even as PC and phone units contract. FQ3 2026 (Tier 1, SEC-filed): revenue $41.46B vs $9.30B a year earlier, GAAP diluted EPS $24.67, operating cash flow $25.39B, FQ4 guidance revenue $50.0B +/-$1.0B at ~86% gross margin. Corroborating demand signal: Nvidia is being forced to cut memory content because memory is 29% of its BOM - that is supplier pricing power showing up in a customer's product design. Bear: an 85% gross margin is roughly 25 points above any historically sustainable level, and a 5x forward multiple on peak-cycle earnings is the textbook signature of a cycle top, not a bargain. Customer inventories have moved from 2-4 weeks to 7-9 against an 8-week warning threshold and a 10-week exit trigger. ↔ deep-dive | Peak-cycle earnings at a trough multiple - the classic value trap in semis; CXMT's +466% Shanghai IPO debut reframes Chinese commodity-DRAM supply risk (counter-argument: China's progress is in commodity DRAM, not HBM, where the West leads through 2027+); Customer inventories 7-9 weeks vs an 8-week warning threshold; Highest-variance name on either list - the 12-month distribution is genuinely bimodal, not merely uncertain | 77 |
| GEV | Electricity, not silicon, is the binding constraint on AI. GEV sells the scarcest physical asset in the buildout - gas turbine slots - into a multi-year sold-out book. Q2 2026 (Tier 1, company release): orders $24.2B +88% organic, backlog $176B (+$13.0B sequentially), gas power equipment backlog 100GW to 116GW, revenue $11.1B +22%, adjusted EBITDA margin +340bps organic to 11.3%, free cash flow $5.1B IN THE QUARTER - more than all of 2025. FY26 FCF guidance raised from $6.5-7.5B to $11.5-12.5B. The $200B backlog target previously set for 2027 has been pulled forward a full year. Strongest verified estimate-revision evidence on either list. | Highest headline multiple on this list at ~52x forward; Wind segment remains a drag; Turbine slot reservations are not firm revenue; If AI capex is cut, orders reverse with a lag - and a one-year New York State moratorium on 50MW+ data centers shows regulatory bottlenecks are now real | 76 |
| LLY | Clear structural winner of the GLP-1/obesity duopoly, and the contrast is quantitative rather than narrative: Lilly is compounding roughly 29% EPS while Novo Nordisk has guided 2026 to a 5-13% constant-currency SALES DECLINE. Oral orforglipron extends the franchise past injectable supply constraints. Included as much for portfolio construction as for absolute upside - it is the only top-10 upside name with no exposure to the hyperscaler capex question. | Consensus PT implies only ~11% upside - the easy multiple expansion is behind it; Oral pill data was characterised as disappointing by some outlets; US drug pricing / most-favored-nation policy risk; 34x forward leaves no room for a manufacturing stumble | 74 |
| GOOGL | Best full-stack AI position in the world - TPUs, models, distribution and cloud - and the only Mag-7 name whose REVENUE growth accelerated on the back of AI. Q2 2026: revenue $119.8B +24% (twelfth straight double-digit quarter), operating income $40.8B +30% at a 34.0% margin, Google Cloud $24.8B +82% with cloud operating margin expanding to 35.6% from 20.7%, and a $514B cloud backlog - more than 4x annualized cloud revenue. | This is why it ranks 8th and not 1st: 2026 capex raised to $195-205B, Q2 free cash flow -$5.9B (first negative quarter since the 2004 IPO), buybacks suspended. Alphabet's negative FCF print is literally what triggered the Nasdaq-100 correction; Street models FCF going from +$13B in 2026 to -$13B in 2027; EARNINGS QUALITY: Q2 diluted EPS of $9.11 was materially inflated by unrealized equity-securities gains (one Tier-2 source puts ~80% of Q2 earnings as one-time marks on Anthropic/SpaceX stakes - independently UNVERIFIED). Do not use that EPS in a valuation subscore, and treat FactSet's 112.4% Comm Services growth figure with the same caution; Antitrust remedies remain live | 73 |
| META | CONTRARIAN, and the tension is the point. You are paying 17.6x forward - the cheapest multiple in mega-cap tech - for a business growing revenue 28% with ad impressions +14% and price-per-ad +12%. The core business is not broken; it is accelerating. The entire de-rating is a capex/ROI question, not a demand question. Q2 2026 (reported after the close on RUN_DATE): revenue $60.80B +27.96%, EPS $6.18 vs ~$7.22 expected, operating margin compressed to 31% from 43%, free cash flow $784M vs $8.55B, including a $2.4B legal settlement and $1.18B severance, with 2026 capex guided to $130-145B. NOTE: the -9.7% move on this print occurred on Jul 30, OUTSIDE the RUN_DATE window, and is excluded from Track A. ↔ deep-dive | The structural flaw: unlike MSFT, GOOGL and AMZN, Meta has NO external cloud revenue line to monetize the buildout - its AI capex carries no third-party revenue offset; Reality Labs lost $4.03B in the quarter; If 2027 capex guides higher again the multiple can compress further from here; Longest losing streak on record at 11 sessions; short interest at its highest since 2022; Highest-conviction VALUATION case and lowest-conviction CAPITAL ALLOCATION case on the list - hence the split sub-scores (90 valuation / 45 revisions) | 66 |
| VRT | Pure play on data-center thermal management and power distribution - the physical bottleneck layer. Rack densities from Rubin-class systems make liquid cooling non-optional, converting a cyclical hardware business into a content-per-rack growth story. Appears on BOTH tracks this run: Track A falling rank 3 on the -17.26% Jul 29 print, Track B upside rank 10 on the multi-year thesis. That is the design working, not a contradiction - the daily and 12-month tracks are scored independently. | Highest beta on this list to any hyperscaler capex cut; Competitive entry from Schneider and Eaton; The Q2 2026 revenue miss ($3.27B vs $3.38B) is exactly the kind of execution slip a 29x forward multiple cannot absorb repeatedly; Ranked last on this list precisely because the Track A evidence actively cuts against the Track B thesis this week | 63 |
▼ Downside skew — 1yrconviction
| Ticker | Thesis | Key risk | Score |
|---|---|---|---|
| ORCL | The only name on either list where the risk is solvency-adjacent rather than valuation. Oracle levered its balance sheet to fund a ~$300B OpenAI contract and the credit market has repriced it: CDS spreads hit an all-time record 198.23bp and S&P downgraded it to BBB- in the week of Jul 13 - one notch above junk, which would force selling by investment-grade-mandated funds. It is the largest non-financial corporate borrower in Bloomberg's US high-grade index. A Wisconsin data-center project required a $7B collateral posting because BBB falls below the single-A regulatory threshold, costing over $100M/yr. Total liabilities $218.7B against $43.06B of equity, with ~$40B of further financing planned for FY2027. | THE HONEST COUNTER-ARGUMENT: the stock is already -49%, 14.6x forward is not demanding, and the 3-year EPS growth forecast is 27.37%. The bear case here is CREDIT, not earnings - it resolves on refinancing dates, not on quarters; Any OpenAI equity or financing event that de-risks the counterparty; A successful $40B raise at reasonable spreads would collapse the CDS and the thesis with it | 78 |
| INTC | A 4.5x move in twelve months on a company still losing $11B a year, driven by POLICY and PARTNERSHIP headlines rather than profits - $8.9B of CHIPS funding converted to a government equity stake, a $5B Nvidia investment, and an Apple chip-making agreement. At 54.8x forward it is the most expensive large-cap semi on either list by a wide margin with the weakest competitive position and no trailing earnings at all. The tell that positioning is reflexive rather than fundamental: INTC fell 31.9% in the first half of July alone while still up 158% YTD, and finished July -41.36% ($139.63 to $81.88), its worst month since September 2000. | A sovereign/strategic backstop makes a fundamental short genuinely dangerous - the US government is now an equity holder; 18A/14A yield news is binary and headline-driven; Server CPU demand is genuinely strong; Consensus PT of $115.27 sits 26% ABOVE spot - the Street is not on this side of the trade | 75 |
| NVO | The cleanest VERIFIED downward-revision case on either list. The company guided 2026 to a full-year sales decline of 5-13% at constant currency (announced 2026-02-03) against 10% growth in 2025, driven by US market-access and demand pressure, with the CEO warning it 'will get worse before it gets better'. Novo has also cut US GLP-1 prices by up to 70%, defending volume at the cost of mix. The sell-side has not finished cutting: consensus PT of $47.23 sits 8.4% BELOW spot - one of only two names in this entire artifact where that is true. | A trailing P/E of 12.1 is genuinely cheap and limits downside velocity; A price-cut-driven volume inflection, or a strong oral launch, could stabilize the story; Already -25% over twelve months, so a meaningful portion is priced | 75 |
| CRWV | $35B of debt against $40B of equity value, funding depreciating GPUs, with -$10.6B of free cash flow. Altman Z-Score 0.36 and Piotroski F-Score 2 both sit in elevated-distress territory. This is the highest-beta, lowest-quality expression of the AI capex trade and therefore the first place a funding-market tightening shows up - which matters acutely in a regime where the Fed's next move is priced toward a hike. Also a central node in the 'circular financing' critique (Nvidia backstops the neocloud, the neocloud books Nvidia revenue). Options confirm the market treats it as a volatility instrument: 30-day IV 109 on Jul 28 rising to 115 intraday Jul 29 against a 52-week range of 67-124. | Contracted revenue with investment-grade counterparties is real and materially de-risks the near term; ~99% 3-year revenue growth forecast; Nvidia's strategic support is an explicit backstop; Borrow cost is likely punitive and the -32% move means much is already priced; Consensus PT of $138.03 is 87% above spot | 75 |
| MRK | Merck has rallied 57% INTO the Keytruda loss of exclusivity, and the deterioration is already visible in aggregate estimates: FactSet attributes the Health Care sector's Q2 downward revision (-8.9% to -17.8%) specifically to Merck and Gilead. The company has announced $3B of annual cost cuts ahead of the cliff - a defensive signal, not an offensive one. Paying 21x forward for 5.6% EPS growth against a patent cliff is the worst growth-adjusted multiple among mega-cap pharma. Reports Aug 4 BMO with consensus EPS of -$0.26. | Pipeline or M&A can re-rate it - the company is actively acquisitive; Subcutaneous Keytruda conversion could materially blunt the cliff, and a KEYTRUDA QLEX sNDA has a PDUFA date of Aug 17; A 2.6% dividend limits downside velocity; Consensus PT is still above spot, if only by 4.2% | 73 |
| TSLA | $1.22 trillion of market capitalization resting on $3.81B of earnings. In a regime where the Fed's next move is priced toward a HIKE and long-duration multiples are compressing across the board, Tesla carries the largest pure discount-rate exposure of any US mega-cap. The underlying auto business is a 14%-growth, 3.7%-net-margin manufacturer; the entire valuation is optionality on robotaxi and Optimus with no verifiable revenue line. Capex is up 142% to ~$25B and free cash flow is negative. | ESTIMATE-REVISION DIRECTION IS UNVERIFIED for TSLA in this pass - the sub-score is set to neutral 50 rather than guessed; Persistent retail bid (AltIndex meme-stock tracker had TSLA at 252 mentions, +89.5%); Any credible autonomy milestone re-rates it violently; Consensus PT of $398.30 is still 29% ABOVE spot | 72 |
| AAPL | The most valuable company in the world trades at 36.6x forward for ~11% growth, and the sell-side consensus target sits BELOW spot - a rare and mechanically bearish configuration (only NVO shares it in this artifact). Apple is the clearest AI laggard among mega-caps: WWDC 2026 passed with no launch deadline for the Siri overhaul, and the strategy has shifted to routing Siri through RIVAL models (Gemini, Claude) in iOS 27 - an admission of platform dependence. China remains weak. Reports Jul 30 AMC with an implied move of only 3.42-4.3%, i.e. roughly $170B of market value at risk on the smallest relative event premium of the mega-cap slate. ↔ deep-dive | $123.3B of TTM free cash flow and the largest buyback in history put a hard floor under it; Any credible AI/Siri launch closes the narrative gap instantly; A compelling iPhone upgrade cycle fixes the growth rate outright; Trading 22.6% above its 200-day moving average into the print - momentum is against the short | 71 |
| PLTR | After a 22% decline the stock still trades at roughly 56x SALES. The balance sheet is pristine and the growth is real, so this is explicitly NOT a business-quality short - it is a pure multiple-compression short in a regime where multiples are compressing and the Fed's next move may be a hike. At 56x sales a 53% grower needs roughly five years of flawless execution just to reach a normal software multiple. Reports Aug 3 AMC - the marquee report of that day. retail-heavy | Government and defense budget tailwind ($1.5T FY27 request); Extremely strong retail base cuts both ways - Tier-3 support is real but ApeWisdom shows PLTR mentions -73% over 30 days, so the retail bid may be thinning; Crowded short; Consensus PT of $182.20 is 49% above spot | 67 |
| AMD | AMD trades at 2.5x Nvidia's forward multiple while being the structurally weaker accelerator franchise - squeezed from above by Nvidia's ecosystem and from below by Broadcom, Google TPU and Meta MTIA custom silicon. It faces the same memory-cost inflation now hitting Nvidia's bill of materials WITHOUT Nvidia's pricing power. A 174% twelve-month move has front-loaded several years of MI-series success. Reports Aug 4 AMC. | Genuine second-source demand from hyperscalers who want a Nvidia alternative is real and structural; Server CPU share gains against Intel are real and margin-accretive; A 46.6% revenue growth forecast is not fantasy; This is a relative-value short (vs NVDA) far more than an absolute one | 66 |
| WDAY | The cleanest pure-play on the seat-based-SaaS de-rating. HCM headcount licensing is the most literally AI-exposed pricing model in enterprise software: if AI reduces headcount, Workday's billable units shrink mechanically. Morgan Stanley initiated coverage at Underweight with a $145 target on 2026-07-21 - below spot - acknowledging Workday has 'the strongest moat in enterprise software' while concluding its AI initiatives are 'unlikely to generate meaningful growth acceleration in the near term'. | 15x forward is not expensive; Consensus is still Buy across 41 analysts with a PT above spot; Morgan Stanley itself concedes the moat; AUDIT NOTE: the same firm published in March 2026 that AI-disruption fears in software are 'overblown' and that profits across the group have held up, then downgraded ADBE and initiated WDAY at Underweight in July. That internal inconsistency is why this whole cohort ranks in the bottom third of the list rather than the top | 66 |
C · Options Heat
Where the premium is paying up
| Ticker | Signal | Read | Implication | Lag |
|---|---|---|---|---|
| MU | iv_spike | 30-day IV 97 vs 52-week range 40-108; call:put 1.1:1 (balanced) | Two-way hedging and gamma demand at near-record vol, not directional conviction. Consistent with forced de-risking rather than a positioning view. | Market Rebellion pre-market report Jul 29, reflecting the Jul 28 close. Broker-desk snapshot, NOT exchange data. No vol/OI table retrievable - Barchart and Market Chameleon render UOA client-side and returned page chrome only. |
| SNDK | iv_spike | 30-day IV 143 vs 52-week range 44-163; call:put 1:1 | Near-record implied vol with zero skew - a pure volatility event. Reports Aug 5 AMC so event premium should persist through the horizon. | Market Rebellion pre-market Jul 29 (reflects Jul 28 close). Broker-desk snapshot; no exchange vol/OI. |
| NBIS | iv_spike | 30-day IV 156 (Jul 28) and 153 (Jul 29 intraday) vs 52-week range 65-167; skew 1:1.1 puts flipping to 1:1 | IV pinned at the top of its annual band with unstable skew - the profile of a name being traded, not held. Confirmed by a -9.7%/-12.7%/+26.2% three-session sequence. | Market Rebellion pre-market + mid-session Jul 28/29. Mid-session figures are intraday and non-final. |
| VRT | iv_spike | Weekly IV 159 vs August 86 = 1.85x term-structure ratio; Benzinga implied move 11.38%; realized -17.26% | Rich event premium that STILL underpriced the downside by ~50%. A caution against reading implied moves as a bound in this regime. | Market Rebellion mid-session Jul 28 + Benzinga screen published Jul 26 (3 days pre-event). No post-print flow available. |
| KLAC | pc_skew | 30-day IV 107 with weekly/August 1.07x (flat term structure); call:put 1:1.5 skewed to PUTS; Benzinga implied move 19.08% | Bearish. The clearest single-name put skew in the pre-earnings set and the only one in this dataset that actually called the direction (-10.80%). | Market Rebellion mid-session Jul 28, pre-event. Volume ratios do NOT identify buy vs sell side. |
| SOFI | pc_skew | Weekly IV 128 vs August 70 (1.83x); call:put 2.5:1 to CALLS; EarningsWatcher implied +/-10.1% | Heavy pre-print call skew that was wrong-footed - stock fell 8.9% on a beat-and-raise. Illustrates why a call ratio is not a bullish signal: it is equally consistent with overwriting. | Market Rebellion mid-session Jul 28. No bid/ask side tagging available on any free source. |
| MSFT | vol_oi | Pre-print: weekly IV 111 vs August 48 (2.06x), straddle 392.50 pricing a 7% move, call:put 2.1-2.2:1. Post-print: 322,000 calls in the first 30 minutes = 8x average intraday volume, most popular Aug 450 call | Bullish chase, high confidence - but the pre-print options market UNDERPRICED the outcome by ~2x (7.0-7.3% implied vs 14.8% realized). Post-print flow is Jul 30 data, i.e. AFTER the RUN_DATE window. | Pre-print from Market Rebellion Jul 29 (intraday). Post-print from Schaeffer's, published Jul 30 - next-day reported and therefore lagged. Not knowable on RUN_DATE. |
| META | vol_oi | Pre-print: weekly IV 128 vs August 54 (2.04x), straddle 592.50 pricing a 9% move, call:put 2.0-2.4:1 concentrated in the 590 calls. Post-print: 70,000 puts = 4x average, led by the 7/31 500-strike put, with the Sep 460 put showing sell-to-open | Bearish with a contrarian wrinkle - someone is writing downside into the fall. Realized -9.7% landed roughly in line with the implied. | Same as MSFT. Post-print figures are Jul 30, outside the RUN_DATE window. |
| AAPL | iv_spike | Straddle 340 pricing a 3.42-4.3% implied move into Jul 30 AMC (~$170B of market value); call:put 1.2:1 | The SMALLEST relative event premium of the mega-cap slate despite the largest absolute dollar exposure - the options market is not pricing an Apple surprise. | Market Rebellion Jul 29 pre-market + Benzinga Jul 29. Free aggregators, pre-event. |
| AMZN | iv_spike | Straddle 230 pricing a 6.04-7.5% implied move (~$150B) into Jul 30 AMC; call:put 1.3:1; trading 1.4% BELOW its 200-DMA | Widest implied move of the mega-caps. Short interest reported at its highest since 2022 while the options chain P/C sat at 0.32 - i.e. record shorting alongside heavy call ownership. Genuinely two-sided. | Benzinga Jul 29 + 247wallst Jul 28 (P/C figures undated within the article; assume Jul 27-28). Prediction-market beat odds cited in that piece are Tier 3 and excluded. |
| SPCX | iv_spike | 30-day IV 115 vs 52-week range 70-116 (at the annual high); call:put 1.5:1; CNBC reported options pricing a 15% implied move into the Aug 4 maiden print | The single most asymmetric event in the catalyst horizon: first-ever earnings report as a public company, immediately followed by a tiered insider lock-up opening Aug 6 (up to 911.5M shares), against reported short interest near one-third of available float. | Market Rebellion Jul 29 pre-market; CNBC video headline verified but body not fetched (403). Market cap ($2.0T) from MacroTrends as-of 2026-07-13 and therefore STALE. |
| CBOE_EQUITY_PC | pc_skew | Total P/C 0.96 (9-day avg 0.95), Equity P/C 0.71, Index P/C 1.11 - all as of Jul 28, 2026 | Hedging demand is concentrated in INDEX puts, not single-stock puts - institutions buying macro protection into the FOMC and mega-cap earnings while single-name speculation stayed call-tilted. Corroborated by put-side unusual volume in XLP, ITB and RSP (sector/broad hedges) on Jul 28. | CRITICAL: the Jul 29 CBOE reading is UNVERIFIED. The official CBOE daily statistics page returned navigation content only; YCharts had not updated past Jul 10 (equity) / Jul 2 (total). Jul 28 via thetrading.tools is a ~1-session lag. Given the Jul 29 VIX spike to 20.66 the total P/C almost certainly printed higher - but that is an INFERENCE, not a datum. A third source (Convex) shows an 'equity' series running ~2x the CBOE band and was DISCARDED as methodologically incompatible. |
| DRAM_COMPLEX | iv_spike | SKHY IV 123 (52wk 120-139) 1.5:1 calls; WDC IV 109 (52wk 33-117) 1:1.6 PUTS; Roundhill DRAM ETF IV 104 (52wk 58-107) with 3.5:1 CALLS on a -20% five-session drawdown | The entire memory complex sat at or within a few points of 52-week IV highs on Jul 29. The DRAM ETF's 3.5:1 call skew at near-record IV is a dip-buying/bounce-speculation signature; WDC's 1:1.6 put skew makes it the outlier bearish name in the group. ETF excluded from ranked lists by universe filter. | Market Rebellion pre-market Jul 29 (reflects Jul 28 close). Broker-desk snapshot. |
| OIL_COMPLEX | iv_spike | UCO, BNO and USO all flagged 'IV rising' intraday Jul 29; WDS saw 4,000 Aug 25 calls; BIPC 2,600 Aug 45 calls with shares +3% | Bullish energy positioning confirming the geopolitical bid rather than a mechanical sector rotation. ETFs excluded from ranked lists. | Market Rebellion mid-session Jul 29 - intraday and non-final. |
| NVDA | vol_oi | Context example from Jul 22 (outside window): 5,800 Aug-3 $235 calls = 43x prior OI at $0.43 premium with the stock at $214.01 | Included as a METHODOLOGY CAVEAT, not a signal. Barchart's own author read this as OTM call SELLING (covered-call overwriting) - a bearish-to-neutral posture - despite a 43x vol/OI ratio. Volume-to-OI alone is directionally ambiguous without side tagging, which no free source provides. | Barchart via Yahoo, 2026-07-22, outside the 48h window. Included for interpretive discipline only. |
D · Catalyst Calendar
Upcoming events
| Date | Event | Tickers | IV move |
|---|---|---|---|
| 2026-07-30 | Q2 2026 GDP advance release (cons. +2.1% QoQ), June PCE / Personal Income & Outlays (core PCE consensus CONFLICTS across sources - UNVERIFIED), initial jobless claims (cons. 187K), all 8:30 ET | macro | unknown |
| 2026-07-30 | FQ3 2026 earnings, AMC (mcap $4.72-4.98T). Consensus EPS $1.88 | AAPL | low |
| 2026-07-30 | Q2 2026 earnings, AMC (mcap $2.51T). Consensus EPS $1.81; ~$200B capex guide expected | AMZN | high |
| 2026-07-30 | Large-cap earnings, BMO. PWR implied move 11.96% | MASHELBMYMOSOTTSNYPWRVLOKKRRACEICECIREGNAPDYUM | normal |
| 2026-07-30 | Earnings, AMC. Implied moves: MPWR 17.81%, RDDT 13.4%, RIVN 11.3%, COIN 10.8%, FSLR 10.4%, MSTR 9.5%. RBLX weekly call IV 250 vs August 101 with 3.5:1 call skew | SYKMPWRCOINRBLXMSTRRDDTRIVNFSLRILMNMTDNBIX | high |
| 2026-07-30 | Bank of England MPC decision (no August meeting follows). Affects LYG, NWG, UK-exposed ADRs | macro | unknown |
| 2026-07-30 | Bank of Japan MPM day 1 of 2 | macro | unknown |
| 2026-07-31 | Employment Cost Index Q2 (cons. +0.9% QoQ) 8:30 ET; Chicago PMI (56.7) 9:45; U. Michigan final July sentiment (49.5) 10:00 | macro | unknown |
| 2026-07-31 | BANK OF JAPAN rate decision + quarterly Outlook Report. Flagged as a yen-carry-trade focal point; affects MUFG, SMFG, MFG, NMR, HMC and broad risk assets via carry unwind | macro | unknown |
| 2026-07-31 | Q2 earnings, BMO (XOM $650.5B cons. $3.87; CVX $387.9B cons. $5.81). Implied moves XOM +/-5.4%, CVX +/-5.1%. Both sit on a live geopolitical crude premium | XOMCVX | normal |
| 2026-07-31 | Large-cap earnings, BMO. ABBV implied +/-5.7%. MRNA is a DOUBLE CATALYST - earnings Jul 31 plus a PDUFA date Aug 5 | ABBVLINUBSETNENBCLARESCCJTROWMRNALYBCBOE | normal |
| 2026-08-02 | OPEC+ ministerial meeting (Sunday) to set September output. NOTE: reporting CONFLICTS on the direction of the July decision - CNBC described an output increase, other outlets a ~188 kb/d cut by seven nations. Direction UNVERIFIED; the meeting date is verified. Market reaction lands Aug 3 | XOMCVXSHELBPOXYFANGDVNEOGVLOMPCPSX | unknown |
| 2026-08-03 | ISM Manufacturing PMI July (cons. 53.3) 10:00 ET; Construction Spending June; US Treasury quarterly refunding marketable borrowing estimates + TBAC statements | macro | unknown |
| 2026-08-03 | Q2 earnings, AMC (mcap $295.8B, cons. EPS $0.28). Marquee report of the day; PLTR is Track B downside rank 8 | PLTR | high |
| 2026-08-03 | Large-cap earnings (mixed BMO/AMC) | VRTXWMBOKEFANGONMARMELITSNMUFGVNOMJAZZCLX | normal |
| 2026-08-04 | International trade in goods & services June (balance cons. -$77.6B) 8:30 ET; JOLTS job openings June (cons. 7.594M) 10:00 - date verified against the BLS JOLTS schedule after an aggregator conflict; Factory Orders June | macro | unknown |
| 2026-08-04 | SpaceX FIRST-EVER earnings report as a public company, AMC, webcast 4:30 ET (mcap ~$1.5-2.0T, figures conflict). Options priced a ~15% implied move. Triggers a tiered insider lock-up whose first tranche opens Aug 6 - up to 911.5M shares, with an extra 10% unlocking if the stock closed >=30% above the $135 IPO price on >=5 of the 10 sessions before earnings (Musk excluded). Short interest reported near one-third of available float; net loss $4.28B in Q1 2026 | SPCX | high |
| 2026-08-04 | Q2 earnings, AMC (mcap $791-851B, cons. EPS $1.35). AMD is Track B downside rank 9 | AMD | high |
| 2026-08-04 | Large-cap earnings, BMO. CAT is Track A falling rank 9 (cons. $6.25); MRK is Track B downside rank 5 (cons. -$0.26) | CATMRKMCDPFEBPDUKSPOTCMIMPCAPOGWW | normal |
| 2026-08-04 | Large-cap earnings, AMC | ANETAMGNGILDBKNGEMREOGSUDVNALABPINSLSCCTOSTWYNN | normal |
| 2026-08-05 | ADP National Employment Report July 8:15 ET (June actual +98,000) - the leading tell for the Aug 7 payrolls print that sits just OUTSIDE this horizon; ISM Services PMI July (cons. 54.0) 10:00; US Treasury quarterly refunding statement + TBAC report | macro | unknown |
| 2026-08-05 | PDUFA goal date for mRNA-1010 seasonal influenza vaccine. FDA VRBPAC voted 9-0 in favor on 2026-06-18 (separate 9-0 votes for adults 50-64 and 65+). Second leg of a double catalyst after Jul 31 earnings | MRNA | high |
| 2026-08-05 | Q2 earnings, BMO (mcap $1.126T, cons. EPS $6.71). Largest single-name catalyst of the day; LLY is Track B upside rank 7 | LLY | normal |
| 2026-08-05 | Earnings, AMC (SNDK fiscal Q4/FY26, cons. $33.28; WDC cons. $3.24). SNDK is Track A falling rank 2 with PUMP_RISK flagged. Sandisk also announced an Investor Day for Aug 13 | SNDKWDC | high |
| 2026-08-05 | Large-cap earnings (mixed BMO/AMC). NVO is Track B downside rank 3 | DISSHOPCVSUBERPSXCORKHCGFSAPPMCKDASHOXYEBAYXYZAXONEXPENVOHUBSCRCLIONQ | normal |
E · Trade Ideas
What the data implies
MUneutral · track A/B
Rationale Deliberately framed as NEUTRAL rather than long or short, because the evidence is genuinely bimodal and saying so is more useful than picking. Long case: 5.15x forward earnings, FQ4 guidance of $50.0B revenue at ~86% gross margin (Tier 1, SEC-filed), and Nvidia cutting memory content because memory is 29% of its BOM. Short case: an 85% gross margin is ~25 points above any sustainable level, customer inventories have moved from 2-4 weeks to 7-9 against an 8-week warning threshold, and CXMT's +466% Shanghai debut reframes commodity DRAM supply. Balanced 1.1:1 options skew at near-52-week-high IV says the options market has no view either.
Invalidation LONG invalidated if customer inventories cross 10 weeks (the stated exit trigger) or if FQ4 gross margin guidance is cut. SHORT invalidated if HBM contract pricing holds into the Q3 renewal round or if the +13-18% Q3 DRAM contract price forecast is exceeded.
Risk Highest-variance name in this artifact. Market cap and Jul 29 close both carry unresolved source conflicts - size off verified fundamentals, not off the quoted price. Also note the Track A signal (falling rank 1) and the Track B signal (upside rank 5) point in OPPOSITE directions by design; do not net them.
TSMlong · track B
Rationale The chokepoint that converts the capex boom into cash rather than consuming it, at 17.75x forward against raised 40%+ 2026 revenue growth guidance and 2027 price hikes flagged by multiple brokerages. Unlike every hyperscaler on the upside list, TSMC's free cash flow improves as the buildout continues rather than inverting.
Invalidation A cut to the 40%+ revenue growth guidance or to the $64B capex plan; any Taiwan Strait escalation that changes the geopolitical discount rate - the latter invalidates instantly and is not hedgeable within the position
Risk Single-point geopolitical tail risk is the whole bear case. Also carries high capex_beta - do not hold alongside NVDA, AVGO, GEV and VRT and call it diversification.
ORCLshort · track B
Rationale The only solvency-adjacent name on either list: CDS at a record 198.23bp, S&P downgrade to BBB- (one notch above junk, below the threshold that forces IG-mandated selling), $167.43B of total debt against $43.06B of equity, TTM free cash flow -$23.69B, and ~$40B of further financing planned for FY2027 - all in service of a ~$300B OpenAI contract. In a regime pricing a Fed HIKE, this is where funding tightening shows up first.
Invalidation A successful ~$40B raise at reasonable spreads, an S&P outlook stabilization, or any OpenAI equity/financing event that de-risks the counterparty. Note this resolves on REFINANCING DATES, not on quarterly earnings - a good quarter does not invalidate it and a bad one does not confirm it.
Risk Stock is already -48.97% over 52 weeks and 14.6x forward is not demanding - much of the equity-market damage is done. This is a credit thesis being expressed in equity, which is an imperfect instrument.
SPCXneutral · track A
Rationale The most asymmetric scheduled event in the horizon and the one with the least usable prior. First-ever public earnings report Aug 4 AMC with options pricing a ~15% implied move and 30-day IV at the top of its 52-week range (115 vs 70-116), immediately followed on Aug 6 by a tiered lock-up releasing up to 911.5M shares - into reported short interest near one-third of available float. Two opposing forces (a squeeze setup and a supply cliff) resolve within 48 hours of each other.
Invalidation n/a (volatility view). The directional read only becomes tradeable AFTER the print clarifies whether the extra 10% unlock tranche triggered.
Risk No earnings history whatsoever - no base rate for how it reacts. Market cap source (MacroTrends, $2.0T) is dated 2026-07-13 and STALE; a second source implies ~$1.5T. Do not size off a stale cap.
XOMCVXlong · track A
Rationale The window's only working macro hedge. Energy (+1.9%) was the sole meaningfully green sector on a day nine of eleven closed red, driven by an actual state-level military exchange (IRGC ballistic missiles at US forces in Jordan) plus a Houthi tanker attack threatening Bab-el-Mandeb. Both names report Jul 31 BMO and OPEC+ meets Aug 2 - three catalysts inside the horizon.
Invalidation A credible de-escalation or renewed ceasefire that unwinds the crude risk premium - note this narrative ALREADY reversed once inside the 48h window (oil fell 6% on Jul 27 ceasefire reports before rallying 6.6% on Jul 29 re-escalation). Also invalidated by an OPEC+ output increase on Aug 2, where the reported direction of the prior decision is itself UNVERIFIED.
Risk Two-sided and headline-driven, with a documented same-week reversal. XOM was also downgraded to Neutral at BofA on Jul 28. This is a hedge against the inflation/geopolitics leg of the regime, not a fundamental energy call.
NVOshort · track B
Rationale The cleanest verified downward-revision case in the artifact: company-guided 2026 constant-currency sales DECLINE of 5-13% against 10% growth in 2025, US GLP-1 price cuts of up to 70% defending volume at the expense of mix, and a consensus price target ($47.23) that sits 8.4% BELOW spot - the sell-side has not finished cutting. The mirror-image long is LLY (Track B upside rank 7), which is compounding ~29% EPS against the same end market.
Invalidation A volume inflection from the price cuts showing up in quarterly scripts, or strong oral-formulation launch data. Reports Aug 5.
Risk Trailing P/E of 12.1 is genuinely cheap and limits downside velocity; already -25% over 52 weeks. The pair expression carries far less category risk than the outright.
KLACNXPIneutral · track A
Rationale Framed as an OBSERVATION, not a position. Six large caps beat and were sold on Jul 29 (SOFI, NXPI, KLAC, CNC, TER, STX), including KLA disclosing RPO backlog +60% y/y to $12.5B. That is a REGIME signal, not a company signal: with the 30-year above 5.20% and three Fed dissents favoring a hike, multiple compression is overwhelming EPS. Any Track A model that reads these prints as bearish company evidence will be systematically wrong.
Invalidation The pattern breaks if beats start being rewarded again - watch the Aug 4-5 cohort (AMD, LLY, SNDK, WDC) for whether good numbers get paid. That is the single cheapest regime test available inside the horizon.
Risk The counter-evidence is already on the tape: MSFT was rewarded with +14.8% for the same kind of beat on Jul 30. The rule is not 'beats are punished' - it is 'beats WITHOUT demonstrated AI monetization are punished'.
Methodology & limitations
- NO LIVE OPTIONS TAPE. Barchart's Unusual Options Activity table, Barchart Volume Leaders and Market Chameleon's Unusual Option Volume report all render client-side; fetches returned page chrome only. No ticker-level volume-to-OI table for Jul 28 or Jul 29 was retrievable from any free source. The named options activity in this artifact is the COMPLETE verified set - no vol/OI table was invented to fill the gap.
- NO BID/ASK SIDE TAGGING on any free source. Every call:put figure here is a VOLUME ratio. A 2.5:1 call ratio is equally consistent with call buying and with covered-call overwriting - see the NVDA entry in options_heat for a documented case where a 43x vol/OI print was read by the source's own author as call SELLING.
- CBOE PUT/CALL FOR JUL 29 IS UNVERIFIED. The official CBOE daily statistics page returned navigation content only; YCharts was stale to Jul 10 (equity) and Jul 2 (total). Jul 28 readings are used with an explicit one-session lag. A third aggregator (Convex) reporting an 'equity' P/C running ~2x the CBOE historical band was discarded as methodologically incompatible rather than averaged in.
- NO TIER-1 CONFIRMATION FOR ANY MARKET PRICE. FRED (DGS10, VIXCLS) and CBOE all served stale or navigation-only content. Every price, index level and VIX figure here is Tier 2 (AP wire, financial media) or Tier 3. The FOMC statement is the only Tier-1 macro source obtained.
- UNRESOLVED SOURCE CONFLICTS, published as ranges or flagged rather than point-estimated: gold (~2.2% spread across three sources - NOT point-estimated); Brent (~$2.65 spread, intraday vs settle ambiguity); DXY Jul 29 settlement (only a pre-decision tick and a post-decision range obtainable); Jul 28 Dow closing LEVEL (52,146.49 vs 52,756 across sources, though the point change agrees); MU Jul 29 close ($739 vs $775 within a single article) and MU market cap; CoStar Jul 29 close (-1.65% per price history vs -14% to -14.7% intraday per two media sources) - CSGP was EXCLUDED from the ranked list for this reason; CTSH move magnitude; SHW Jul 28 magnitude (6.0% vs 8.3%).
- INTRADAY-VS-CLOSE HAZARD is the single biggest data risk in this run. Jul 29 saw violent late-session reversals during Chair Warsh's first press conference - indexes briefly turned positive before selling off into the close. MAS, LII, BSX, TER and CSGP all show large intraday-vs-close divergence and were held out of ranked lists rather than published with a possibly-wrong number.
- WINDOW BOUNDARY: MSFT (+14.8%) and META (-9.7%) reported AFTER the close on RUN_DATE. Those price moves occurred on Jul 30 and are deliberately EXCLUDED from Track A. The earnings releases themselves, and the pre-print options positioning, are in-window and are used. Same treatment for the Jul 30 memory snapback (SNDK +18-26%, MU +11%, NBIS +26.18%) - referenced as forward context only, never scored.
- AGGREGATOR STALENESS: ETN (2026-05-28), CEG and VST (2026-05-29) and some GE Vernova statistics fields were stale. ETN, CEG and VST were moved to runners-up and their figures NOT published rather than published stale. SPCX market cap (MacroTrends, 2026-07-13) is stale and flagged inline.
- EARNINGS QUALITY: Alphabet's Q2 diluted EPS of $9.11 was materially inflated by unrealized equity-securities gains and is excluded from its valuation sub-score. One Tier-2 source puts ~80% of Q2 earnings as one-time marks on Anthropic and SpaceX stakes - independently UNVERIFIED and flagged as such. FactSet's 112.4% Comm Services growth figure carries the same caution.
- SELL-SIDE ACCESS: Morgan Stanley, Goldman Sachs, Mizuho, UBS, BofA, Baird, KBW and Citi notes were accessed only as QUOTED EXCERPTS inside Tier-2 media, never as primary research. Tagged Tier 1-quoted where the excerpt is verbatim, Tier 2 otherwise.
- SOCIAL SENTIMENT trackers (Tradestie, AltIndex, ApeWisdom, StockTwits) are scraped, unaudited and non-reproducible historically; several returned a CURRENT snapshot rather than the requested date, which is noted inline where it occurs. Tradestie's #1 ticker for Jul 29 was '$AI' - a known false positive from scrapers mis-tagging the WORD 'AI' - and was discarded, as was '$SK' for SK Hynix text.
- BLOCKED SOURCES: CNBC, Bloomberg and Washington Post returned 403 to automated fetch; CNN, Seeking Alpha and The Globe and Mail are robots-disallowed. Their content appears here only via search-index headlines or third-party citation, and is tiered accordingly.
- DISCARDED SOURCE: a Finviz-hosted item titled 'META, MSFT Making Outsized Post-Earnings Moves' returned figures contradicting every other source and referenced 'fourth-quarter earnings' with a 1/30 expiry - it is a stale January article and was excluded entirely.
- BREADTH is S&P-500-internal (1.8:1 decliners), not the NYSE composite advance/decline line, which was not obtainable for Jul 29.
- SCORES ARE HEURISTIC AND NOT BACKTESTED. Sub-scores are analyst judgment applied to the cited evidence, not a fitted model. Every sub-signal that could not be verified from a free source is set to neutral 50 and flagged - never guessed. Track A options sub-scores are neutral-50 for 6 of 20 ranked names.
- TRACK B FACTOR CONCENTRATION: 9 of 10 upside names and 3 of 10 downside names are expressions of a single variable (does hyperscaler capex hold through 2027). The capex_beta field is provided so this can be neutralised deliberately. LLY is the only top-10 upside name with no capex exposure.
Not financial advice. Educational/analytical only — generated by Daily Market Pulse template v1 - multi-desk subagent research run (market regime, Track A movers, options/sentiment, catalyst calendar, Track B conviction), synthesized 2026-07-30. Do your own diligence.